Evidence map›Paper›PMID 34559866›Full record

ArticlePLoS pathogens2021

TCA cycle remodeling drives proinflammatory signaling in humans with pulmonary tuberculosis.

Jeffrey M Collins, Dean P Jones, Ashish Sharma, Manoj Khadka, Ken H Liu, Russell R Kempker, Brendan Prideaux, Kristal Maner-Smith, Nestani Tukvadze, N Sarita Shah and 6 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
1.9field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Effect of PKM2 onFrontiers in cellular and infection microbiology · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. High-resolution plasma metabolomics and thiamine status in critically Ill adult patients.Metabolomics : Official journal of the Metabolomic Society · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Jeffrey M CollinsDepartment of Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America.ORCID 0000-0002-6574-0873
Dean P JonesDepartment of Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America.ORCID 0000-0002-2090-0677
Ashish SharmaDepartment of Pathology, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Manoj KhadkaDepartment of Biochemistry, Emory University, Atlanta, Georgia, United States of America.ORCID 0000-0002-4003-7049
Ken H LiuDepartment of Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America.ORCID 0000-0002-9736-5828
Russell R KempkerDepartment of Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America.ORCID 0000-0002-7188-4996
Brendan PrideauxDepartment of Neuroscience, Cell Biology, & Anatomy, University of Texas Medical Branch, Galveston, Texas, United States of America.
Kristal Maner-SmithDepartment of Biochemistry, Emory University, Atlanta, Georgia, United States of America.ORCID 0000-0002-2274-4284
Nestani TukvadzeNational Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia.
N Sarita ShahDepartment of Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America.
James C M BrustDepartment of Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York, United States of America.ORCID 0000-0003-3362-1818
Rafick-Pierre SékalyDepartment of Pathology, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Neel R GandhiDepartment of Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Henry M BlumbergDepartment of Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America.ORCID 0000-0002-3110-2443
Eric A OrtlundDepartment of Biochemistry, Emory University, Atlanta, Georgia, United States of America.ORCID 0000-0001-8855-3029
Thomas R ZieglerDepartment of Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Emory University · USAlbert Einstein College of Medicine · USNational Center for Tuberculosis and Lung Disease · GEThe University of Texas Medical Branch at Galveston · US

Funding

Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE)UL1TR002378 · NCATS · EMORY UNIVERSITY · PI Andres J Garcia, Elizabeth O. Ofili · 2017 to 2026
$92.1M
Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Ann M Chahroudi, Colleen F Kelley · 2002 to 2026
$74.0M
Patient and Population Health Outcomes Research SWGP30AI124414 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI Vinayaka R. Prasad · 2017 to 2026
$28.3M
CTSA Administrative Supplement for Informatics Core: A novel AI/ML system to predict respiratory failure and ARDS in Covid-19 patientsUL1TR002556 · NCATS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI KELLER, MARLA J, KIM, MIMI Y · 2018 to 2022
$26.7M
Pilot Project ProgramP30ES019776 · NIEHS · EMORY UNIVERSITY · PI William Michael Caudle · 2013 to 2026
$22.6M
Core-010UL1TR001073 · NCATS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI KELLER, MARLA J, SHAMOON, HARRY · 2013 to 2017
$21.3M
Role of antigen-specific T cell responses in the control of TBU19AI111211 · NIAID · EMORY UNIVERSITY · PI RENGARAJAN, JYOTHI · 2014 to 2020
$20.1M
Training a New Generation of VaccinologistsT32AI074492 · NIAID · EMORY UNIVERSITY · PI Rama Rao Amara, Benjamin A Lopman · 2009 to 2026
$6.4M
Emory-Georgia TB Research Training ProgramD43TW007124 · FIC · EMORY UNIVERSITY · PI HENRY M BLUMBERG, Nestani Tukvadze · 2004 to 2026
$4.6M
Impact of HIV, Antiretroviral Therapy and TB Genotype on Survival in MDR TBR01AI087465 · NIAID · EMORY UNIVERSITY · PI GANDHI, NEEL RAJNIKANT · 2010 to 2014
$3.9M
Safety, pharmacokinetics, and resistance to bedaquiline in XDR TB and HIVR01AI114304 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI BRUST, JAMES C M · 2015 to 2019
$3.7M
Emergence of bedaquiline and clofazimine resistance after interruption of drug-resistant TB therapy in a high HIV prevalence settingR01AI145679 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI BRUST, JAMES C M · 2020 to 2025
$3.6M
FIC NIH HHS D43 TW007124NCATS NIH HHS UL1 TR001073NCATS NIH HHS UL1 TR002378NCATS NIH HHS UL1 TR002556NIAID NIH HHS K23 AI144040NIAID NIH HHS K24 AI114444NIAID NIH HHS K24 AI155045NIAID NIH HHS P30 AI050409NIAID NIH HHS P30 AI124414NIAID NIH HHS R01 AI087465NIAID NIH HHS R01 AI114304NIAID NIH HHS R01 AI145679NIAID NIH HHS R21 AI130918NIAID NIH HHS T32 AI074492NIAID NIH HHS U19 AI111211NIEHS NIH HHS P30 ES019776
6 · The paper itself

Abstract

The metabolic signaling pathways that drive pathologic tissue inflammation and damage in humans with pulmonary tuberculosis (TB) are not well understood. Using combined methods in plasma high-resolution metabolomics, lipidomics and cytokine profiling from a multicohort study of humans with pulmonary TB disease, we discovered that IL-1β-mediated inflammatory signaling was closely associated with TCA cycle remodeling, characterized by accumulation of the proinflammatory metabolite succinate and decreased concentrations of the anti-inflammatory metabolite itaconate. This inflammatory metabolic response was particularly active in persons with multidrug-resistant (MDR)-TB that received at least 2 months of ineffective treatment and was only reversed after 1 year of appropriate anti-TB chemotherapy. Both succinate and IL-1β were significantly associated with proinflammatory lipid signaling, including increases in the products of phospholipase A2, increased arachidonic acid formation, and metabolism of arachidonic acid to proinflammatory eicosanoids. Together, these results indicate that decreased itaconate and accumulation of succinate and other TCA cycle intermediates is associated with IL-1β-mediated proinflammatory eicosanoid signaling in pulmonary TB disease. These findings support host metabolic remodeling as a key driver of pathologic inflammation in human TB disease.

Indexed as

Citric Acid CycleHumansInflammationSignal TransductionTuberculosis, Pulmonary

Identifiers

PMID34559866
PMCPMC8494353
OpenAlexW3200970588

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.